Evidence map›Paper›PMID 41441950›Full record

ArticleCancer causes & control : CCC2025

Bridging the rural cancer gap: why clinical trials must include rural patients.

Ingrid Jacobson, Emily McGovern, Wade Swenson

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Cancer causes & control : CCC, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ingrid JacobsonRural Cancer Institute, Staples, MN, USA. ingrid@ruralcancer.org.
Emily McGovernRural Cancer Institute, Staples, MN, USA.
Wade SwensonRural Cancer Institute, Staples, MN, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oncology clinical trials are not readily available to rural residents in the United States despite rural disparities in preventable cancer incidence, prevalence, and mortality. We comment on the underrepresentation of rural populations in oncology clinical trials, identify key barriers to rural participation, and highlight ways to overcome these barriers, including successful national and international models of inclusive oncology trial design.

Indexed as

Clinical Trials as TopicHealthcare DisparitiesNeoplasmsRural PopulationHealth Services AccessibilityHumansUnited States

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.